Advanced Dermal Filler & Botulinum Toxin Masterclass
COURSE ORIENTATION
Welcome and course purpose
At AESKN Harley Street Aesthetic Academy, This masterclass develops advanced clinical reasoning by connecting patient assessment, functional anatomy, product behaviour, technique selection and early recognition of complications.
Learning outcomes
- Apply layered facial anatomy to treatment planning and risk reduction.
- Identify major vascular pathways, high-risk regions and the limits of the term ‘safe zone’.
- Differentiate filler placement strategies and explain why plane, product, instrument and tissue behaviour must align.
- Assess dynamic muscle balance before planning botulinum toxin treatment.
- Recognise contraindications, cautions and circumstances requiring treatment deferral.
- Recognise common, urgent and rare complications and initiate the clinic’s escalation pathway.
- Document consultation, consent, treatment, aftercare and follow-up to a defensible professional standard.
CERTIFICATE
— PROFESSIONAL PRACTICE
Legal, ethical and prescribing responsibilities
Botulinum toxin type A is a prescription-only medicine in the UK. Treatment must follow a valid patient-specific prescription by an appropriately qualified prescriber, together with the current Summary of Product Characteristics (SmPC), professional standards and local medicines-management policy. Product units are not interchangeable between brands.
- Confirm identity, age, capacity, indication, relevant history, medicines, allergies and previous treatment response.
- Explain material risks, realistic benefits, alternatives, likely duration, review arrangements and costs before consent.
- Document licensed and off-label use clearly. Off-label practice requires enhanced justification, consent and competence.
- Use traceable products from legitimate suppliers and record brand, batch/lot, expiry, quantity and treatment sites.
- Maintain accessible complication support, emergency equipment, referral routes and appropriate indemnity.
PRESCRIBING BOUNDARY
— ASSESSMENT
Consultation and whole-face planning
- Explore the patient’s concern in their own words, motivation, timing and previous experiences.
- Screen for body-image distress, coercion, unrealistic expectations and repeated treatment-seeking without satisfaction.
- Review medical history, pregnancy/breastfeeding status, allergies, autoimmune/inflammatory disease, neuromuscular disorders, infection, dental work, medicines and supplements.
- Assess at rest and in animation under consistent lighting; record baseline asymmetry, ptosis, brow position, smile dynamics, dental show and skin quality.
- Agree a staged plan with conservative endpoints and a clear review window.
— TECHNIQUE
Safety principles before, during and after filler placement
Before injection
- Confirm indication, consent, photography, product, expiry, batch and emergency readiness.
- Mark with the patient upright and animate/palpate relevant structures.
- Establish an aseptic field and prepare skin according to clinic infection-control policy.
- Choose plane, instrument, entry point and endpoint deliberately; define a stop condition.
During injection
- Use controlled hand position, low pressure, slow delivery and the smallest effective aliquot.
- Never inject against unexpected resistance or when the patient reports disproportionate pain.
- Observe colour, capillary refill, pain and tissue behaviour continuously—not only after completion.
- Do not rely on aspiration as proof that placement is extravascular.
- Stop immediately if blanching, livedoid change, escalating pain, visual symptoms or neurological symptoms occur.
After injection
- Reassess symmetry and function before adding product.
- Document sites, plane, instrument, product and total volume.
- Provide written aftercare and a 24-hour emergency contact route.
- Arrange clinically appropriate review; avoid premature correction of normal early swelling.
— EXPERIENCED
Your Expert Trainer
Emel is an expert in non-surgical aesthetic procedures, combining advanced knowledge with a strong passion for aesthetic education and professional development.
As part of AESKN Harley Street Aesthetic Academy, Emel provides expert guidance and practical training across a range of aesthetic courses, supporting delegates from beginner level through to advanced and masterclass training.
With a focus on precision, safety, technique, and the art of aesthetic medicine, Emel helps delegates build the confidence and practical skills needed to enhance their professional practice.
— AFTERCARE
Clear instructions and reliable access to review
Filler aftercare
- Expect temporary tenderness, swelling or bruising; explain what is normal for the treated region and product.
- Avoid touching or applying unclean products until entry sites have closed.
- Seek urgent advice for increasing pain, blanching/mottling, cool or dusky skin, visual symptoms, severe swelling, fever or neurological symptoms.
- Do not massage unless specifically instructed for the product/indication.
Botulinum toxin aftercare
- Explain expected onset and review window using the current product information.
- Avoid unnecessary pressure or manipulation of treated areas immediately after treatment.
- Seek urgent help for swallowing, speech, breathing, visual or generalised weakness symptoms.
- Report asymmetry only after sufficient onset time unless symptoms are concerning.
Safety-net documentation
Record the written advice given, emergency contact route, review plan and the patient’s understanding. Avoid unsupported ritual restrictions; align aftercare with current product information and clinical reasoning.
— BOTULINUM TOXIN
Mechanism, onset and product discipline
Botulinum toxin type A reduces acetylcholine release at the neuromuscular junction, producing temporary, dose- and placement-dependent reduction in muscle activity. Clinical effect develops over days and varies with product, indication, muscle mass, dose, technique and individual biology.
Non-negotiable product principles
- Use only the patient-specific prescribed product and dilution/reconstitution specified by the prescriber and current SmPC.
- Units are product-specific and cannot be converted using a universal ratio.
- Record brand, batch, expiry, dilution, total units, sites, prescriber and administrator.
- Maintain cold-chain/storage requirements and single-patient/single-session rules where stated by the SmPC.
- Do not use a generic internet injection map as a substitute for dynamic assessment.
— EMERGENCY RESPONSE
Suspected filler vascular occlusion
- STOP: cease injection immediately; retain product and batch details.
- ASSESS: pain, colour, capillary refill, temperature, distribution and visual/neurological symptoms.
- ESCALATE: contact the clinic clinical lead/complications service and follow the current written protocol.
- TREAT WITHIN SCOPE: for hyaluronic-acid filler, trained authorised clinicians should initiate hyaluronidase according to the current protocol and re-assess perfusion repeatedly. [4,7]
- TRANSFER: any visual or neurological symptom requires immediate emergency ophthalmic/medical transfer; do not delay transfer for unproven bedside measures. [5,8]
- DOCUMENT: exact onset, findings, photographs, product/site/volume, advice, interventions, response, referrals and follow-up.
- FOLLOW UP: maintain close review until perfusion is stable and tissue outcome is clear; arrange wound/scar support if required.
Vision-loss pathway
Ask about blurred vision, field defect, loss of vision, ocular pain, diplopia, ptosis, nausea, severe headache or neurological deficit. Call emergency services and the receiving ophthalmology service immediately. Record the precise onset time and eye affected. Support transfer and provide product/treatment details. Vision loss after filler is rare but potentially permanent; there is no universally proven reversal protocol, so rapid specialist care is essential.
Precision, plane and diffusion awareness
- Confirm prescription, product, dilution, indication, target muscles and maximum planned dose before preparation.
- Map the observed muscle pattern while the patient is upright; reassess relaxation before injecting.
- Stabilise the tissue and use the depth appropriate to the identified muscle and prescribed plan.
- Use deliberate spacing from vulnerable functional structures; minimise volume and dose consistent with the product plan.
- Treat conservatively where compensatory frontalis activity supports brow position.
- Lower-face and neck treatment carries higher functional consequences for speech, smile, oral competence and swallowing; perform only with advanced competence.
- Review after the expected onset period; avoid premature ‘top-ups’ before the result can be assessed reliably.
A defensible clinical record
- Patient identity, date/time, indication and practitioner/prescriber details
- Medical history, medicines, allergies, previous procedures and relevant examination
- Capacity, consent discussion, alternatives, material risks and cooling-off process
- Baseline photographs and documented asymmetries
- Product, batch/lot, expiry, supplier, dilution where relevant and quantities used
- Treatment map: sites, plane/depth, instrument and techniqu
- Immediate outcome, complications and actions
- Aftercare, emergency contact information and review arrangements
— FAQS
Our Most Asked Questions
Request Consultation
AESKN operates from one of London’s most prestigious medical districts, offering a discreet and professional environment for your treatments.
Address:
Phone:
Book a Private Consultation
Begin your journey with AESKN
Whether you’re new to aesthetics or looking for a more refined approach, we’re here to guide you.
Real Results
